25 of the Best Oncologists Near Me

Dr. Kevin Becker is a medical oncologist who cares for patients with genitourinary cancers, including prostate, kidney and bladder. Dr. Becker received his medical degree from Columbia University College of Physicians and Surgeons in 2004. He completed an Internal Medicine residency and a Hematology and Oncology fellowship at New York Presbyterian/Columbia University Medical Center. In 2020, he received a Master of Medical Management degree from Carnegie Mellon University. He completed the Northwell Health Physician Leadership Development Program in 2021. Dr. Becker's research aims to expand and improve treatment options through cancer treatment clinical trials.Before joining MUSC, Dr. Becker was the Medical Director of the Maimonides Cancer Center in Brooklyn, New York, and Chief of the Regional Division of Hematology and Oncology for Maimonides and Downstate Health Sciences University. Dr. Becker is the Director of Oncology Infusion and Ambulatory Services at MUSC Hollings Cancer Center. Dr. Becker is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes.

Eugene Choi is a Hematologist and an Oncologist practicing medicine in Darby, Pennsylvania. Dr. Choi is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Breast Cancer, Paget Disease of the Breast, and Anemia. Dr. Choi is board certified in American Board Of Internal Medicine and Hematology, American Board Of Internal Medicine.

Nabil Saba is an Oncologist practicing medicine in Atlanta, GA. Dr. Saba is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, Glossectomy, and Tissue Biopsy. Dr. Saba is board certified in American Board Of Internal Medicine, 1997.

Douglas Gladstone is an Oncologist and a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gladstone is currently accepting new patients.

Linda Garland is an Oncologist practicing medicine in Tucson, Arizona. Dr. Garland is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Garland is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Garland is currently accepting new patients.

Al Benson is an Oncologist practicing medicine in Chicago, Illinois. Dr. Benson is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Neuroendocrine Tumor, Ampullary Cancer, Liver Embolization, and Endoscopy. Dr. Benson is board certified in American Board Of Internal Medicine - Internal Medicine (Certified). Dr. Benson is currently accepting new patients.

Dr. Theodore S. Gourdin is a board-certified oncologist specializing in genitourinary cancer. He has a particular interest in treating urothelial cancer of the bladder.His medical degree was awarded by the University of South Carolina School of Medicine. He completed his residency in internal medicine at Tulane University School of Medicine and his fellowship in hematology/oncology at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. ,Dr. Gourdin is accepting patients at the MUSC Hollings Cancer Center in downtown Charleston. Dr. Gourdin is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Muscle Invasive Bladder Cancer. Dr. Gourdin is currently accepting new patients.

Omar Kayaleh, MD, serves as the medical oncology team leader for the Gastrointestinal Cancers Specialty Section and as a member of the Breast Cancer, Genitourinary Cancers, Hematology, Lymphoma/Myeloma and Thoracic/Head and Neck Cancers Specialty Sections at Orlando Health Cancer Institute. He also served as chairman of the Department of Internal Medicine as well as chief of the Hematology/ Oncology Specialty Section at Orlando Health Cancer Institute.Dr. Kayaleh received his medical degree from the University of Florida, completed a residency in internal medicine at Franklin Square Hospital in Baltimore and fulfilled a fellowship at the Medical University of South Carolina.Dr. Kayaleh is board-certified in internal medicine and in the specialties of medical oncology and hematology. He has held many offices and memberships on numerous medical staff committees, including Pharmacy and Therapeutics.He is a member of the Orange County Medical Society, Florida Medical Association, American Medical Association, American Society of Hematology, and the American Society of Clinical Oncology. Dr. Kayaleh is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome. Dr. Kayaleh is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Med. - Medical Oncology. Dr. Kayaleh is currently accepting new patients.

Aaron Gerds is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. Dr. Gerds is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gerds is board certified in American Board Of Internal Medicine, 2013. Dr. Gerds is currently accepting new patients.

Martha Wadleigh is an Oncologist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Wadleigh is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Wadleigh is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Wadleigh is currently accepting new patients.

I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Erba is board certified in American Board Of Internal Med, Hematology. Dr. Erba is currently accepting new patients.

Susan Domchek is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Domchek is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Domchek is board certified in Medical Oncology, 2001. Dr. Domchek is currently accepting new patients.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology. Dr. Kavoussi is currently accepting new patients.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine. Dr. Ambinder is currently accepting new patients.

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner-Johnston is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wagner-Johnston is currently accepting new patients.

Nirmish Singla is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Singla is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Singla is board certified in American Board Of Urology. Dr. Singla is currently accepting new patients.

John Chan is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chan is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Cervical Cancer, Endometrial Cancer, Oophorectomy, and Hysterectomy. Dr. Chan is board certified in Obstetrics And Gynecology - Board Certified , OB & Gyn (Sub: Gynecologic Oncology), Gynecologic Oncology - Board Certified, and Obstetrics & Gynecology. Dr. Chan is currently accepting new patients.

Vincent Picozzi, Jr., MD, specializes in pancreatic cancer, gastrointestinal cancer (pancreaticobiliary), genitourinary cancer, hematologic oncology (lymphomas) and myelodysplasia. Dr. Picozzi is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy. Dr. Picozzi is board certified in American Board Of Internal Medicine, Subspecialty In Hematology, Subspecialty In Medical Oncology. Dr. Picozzi is currently accepting new patients.

Kristie Blum is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Blum is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Blum is board certified in American Board Of Internal Medicine, 2004. Dr. Blum is currently accepting new patients.

Daniel Shevrin, MD, a medical oncologist at Endeavor Health, combines advanced cancer knowledge with compassion and personalized care. He helps patients understand complex diagnoses and collaborates on treatment plans that balance effectiveness and quality of life. Dr. Shevrin is actively involved in prostate cancer research, leading a genomics study to guide more precise therapies for men with advanced disease. He sees each patient as a person first and believes empathy is as essential as evidence-based care. Dr. Shevrin is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Hereditary Neuroblastoma, Non-Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Shevrin is board certified in American Board Of Internal Medicine. Dr. Shevrin is currently accepting new patients.

Michael Grunwald is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Grunwald is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Grunwald is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine, and American Board Of Internal Medicine, Medical Oncology. Dr. Grunwald is currently accepting new patients.

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sehgal is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Sehgal is currently accepting new patients.

John Villeneuve is an Oncologist and an Obstetrics and Gynecologist practicing medicine in West Reading, Pennsylvania. Dr. Villeneuve is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Endometrial Cancer, Endometrial Stromal Sarcoma, Bladder Reconstruction, and Hysterectomy. Dr. Villeneuve is board certified in American Board Of Obstetrics And Gynecology.

Joshua Meeks is an Oncologist practicing medicine in Chicago, Illinois. Dr. Meeks is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Reconstructive Urology Surgery. Dr. Meeks is board certified in American Board Of Urology - Urology (Certified). Dr. Meeks is currently accepting new patients.

Evan Lang is a Hematologist Oncology specialist and an Oncologist practicing medicine in Fairfield, Ohio. Dr. Lang is highly rated in 120 conditions, according to our data. His clinical expertise encompasses Plummer-Vinson Syndrome, Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Lang is board certified in American Board Of Internal Medicine. Dr. Lang is currently accepting new patients.